Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Clinical Epigenetics|October 18, 2023
KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutationsKaiqing Wang, Zhicheng Gong, Yanyan Chen, et al.Pathology, Research and Practice|August 28, 2020
Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancerBingxin Liu, Yuhang Liu, Mingyue Zhou, et al.Cancer Chemotherapy and Pharmacology|May 16, 2019
A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancerGuoying Jin, Yuhang Liu, Jia Zhang, et al.Translational Cancer Research|June 18, 2025
Overexpression of <i>LINC00880</i> promotes colorectal cancer growthGe Gao, Peiwen Xu, Chunyu Yang, et al.Molecular Biology Reports|January 25, 2023
Gamma-Aminobutyric Acid Type A Receptor Subunit Pi is a potential chemoresistance regulator in colorectal cancerTengyu Wang, Qinghao Zhen, Tong Wu, et al.Oncogene|February 25, 2021
Identification of an immune overdrive high-risk subpopulation with aberrant expression of FOXP3 and CTLA4 in colorectal cancerKaisa Cui, Surui Yao, Han Zhang, et al.Translational Cancer Research|July 14, 2026
Si Ni Powder enhances chemotherapy efficacy in sleep-deprived breast cancer via modulation of the tumor microenvironmentHeyuan Jia, Ying Chen, Hao Cheng, et al.Pathology, Research and Practice|December 30, 2025
RAB18 is upregulated in colorectal cancer and promotes tumor progressionHao Cheng, Suzeng Wang, Chunyu Yang, et al.Oncogenesis|August 18, 2018
Correction: Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5pZehua Bian, Jiwei Zhang, Min Li, et al.Oncogene|September 16, 2025
RAB22A triggers intercellular chemoresistance transmission in colorectal cancer by promoting exosome release via the PKM2-pSNAP23 axisYuan Yin, Liang Ming, Yan Qin, et al.Pageof 5